Subscribe
About us
Advertise with us

NeuroSens

Menu

Skip to content

Home
Neurology
Psychiatry

Topic: CMSC 2023

Novel approach to MS therapeutics: anti-CD40L

June 21, 2023

Selected highlights from CMSC 2023

June 6, 2023

Browse by Topic

MS (385)
AD (85)
PD (78)
COVID-19 (58)
BIOMARKERS IN MS (38)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)

EPILEPSY (26)
MIGRAINE (26)
SCHIZOPHRENIA (25)
STROKE (22)
Library (14)
ECTRIMS 2015 (13)
CLINICAL CASES IN MS (12)
AAN 2015 (11)
ECTRIMS 2014 (10)
ECTRIMS 2021 (10)
DEMENTIA (10)
ECTRIMS 2019 (10)
MS SEQUENCING (9)
ECTRIMS 2013 (9)
AAN 2014 (9)
ECTRIMS 2018 (9)
AAN 2013 (9)
PSYCHIATRY (8)
ACTRIMS-ECTRIMS 2020 (7)
AAN 2019 (7)
CHARCOT 2013 (6)
ECTRIMS 2017 (6)
ECTRIMS 2022 (6)
AAN 2021 (6)
ECTRIMS 2016 (5)
ECTRIMS-ACTRIMS 2023 (5)
AAN 2022 (5)
CCSVI (5)
ANXIETY (5)
BIPOLAR (5)
BPD (4)
AAN 2024 (4)
AAN 2023 (4)
NeuroSound (4)
EAN 2015 (4)
PAIN (3)
ENS 2013 (3)
AAN 2017 (3)
EAN 2022 (3)
ACTRIMS Forum 2024 (3)
AAN 2020 (3)
EAN 2023 (3)
SLEEP (2)
EAN 2020 (2)
NEW DRUGS (2)
APA 2014 (2)
SPECIAL REPORT (2)
CMSC 2023 (2)
AAN 2018 (2)
ACTRIMS 2022 (1)
EAN (1)
ECTRIMS (1)
GUIDELINES (1)
LGS (1)
NEWS IN BRIEF (1)
LUMBAR PUNCTURE (1)
ACTRIMS 2023 (1)
SEIZURE (1)
AAN 2016 (1)
APA 2016 (1)
ALS (1)
hATTR (1)
Dravet syndrome (1)
CIDP (1)
CONCUSSION (1)
ADDICTION (1)
EAN 2021 (1)
EAN 2019 (1)
TSC (1)
WEST NILE (1)
INSOMNIA (1)
AAN (0)
EAN 2016 (0)
BIOMARKERS (0)
ECTRIMS 2020 (0)

View all Topics

Popular Posts

McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
Treatment initiation with a higher-efficacy DMT: update from AAN posted on April 25, 2024
Proton pump inhibitors linked to neurological conditions posted on November 29, 2019

Copyright 2024 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)

Contact Us Terms and Conditions